Alnylam Pharmaceuticals (ALNY) Change in Taxes (2009 - 2010)
Alnylam Pharmaceuticals' (ALNY) quarterly Change in Taxes came in at $30000.0 in Q4 2010, down 99.31% YoY from $4.3 million in Q4 2009, and up 2900.0% on a QoQ basis from $1000.0 in Q3 2010.
Alnylam Pharmaceuticals (ALNY) Change in Taxes (2009 - 2010) Analysis & Trends
Alnylam Pharmaceuticals (ALNY) has 2 years of Change in Taxes data on file, last reported at $30000.0 in Q4 2010.
- Quarterly Change in Taxes fell 99.31% year-over-year to $30000.0 in Q4 2010, while the trailing twelve-month figure through Dec 2010 was -$5.5 million (changed N/A YoY) and the FY2010 annual result came in at -$5.5 million, down 1081.16% from the prior year.
- Change in Taxes grew to $30000.0 in Q4 2010, from $1000.0 in the prior quarter.
- In the past five years, Change in Taxes ranged from a high of $4.3 million in Q4 2009 to a low of -$5.5 million in Q1 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 90.33 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Roivant Sciences | 26.20 Bn | 26.20 Bn | 1.16 Mn | -10.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2010 | 30,000.00 |
| Dec 31, 2010 | 30,000.00 |
| Sep 30, 2010 | 1,000.00 |
| Sep 30, 2010 | 1,000.00 |
| Jun 30, 2010 | -1,000.00 |
| Jun 30, 2010 | -1,000.00 |
| Mar 31, 2010 | -5.55 Mn |
| Mar 31, 2010 | -5.55 Mn |
| Dec 31, 2009 | 4.33 Mn |
| Dec 31, 2009 | 4.33 Mn |
| Sep 30, 2009 | -512,000.00 |
| Sep 30, 2009 | -512,000.00 |